Liz Hockley

Articles by Liz Hockley

Pharma

GSK gets appeal go-ahead in licensing clash with AZ

Appeals court sides with GSK unit in licensing dispute over ovarian cancer drug | Judges find fault with previous decision ordering the pharma firm to pay royalties on all sales of an ovarian cancer treatment.   13 February 2024

Pharma

Eagle Pharma launches new suit over leukaemia drug

Oncology specialist seeks to block another bendamustine generic following trio of lawsuits in January | Firm filed complaint for patent infringement against Dr Reddy’s.   6 February 2024

Pharma

Guardant holds on to diagnostics patent following TwinStrand challenge

PTAB says claims of genetic disease testing patent are not obvious | Rival biotech firm denied petition for invalidation.   1 February 2024

MedTech

Delaware jury awards $96.3m damages to Natera over kidney transplant tests

Biotech firm CareDx found to have infringed one of two patents-in-suit through sale of AlloSure and AlloSeq | Damages award consists of $83.6m in lost profits and $12.6m in royalties.   30 January 2024

Pharma

Nivagen accuses India-based big pharma of ‘meddling’ in patent application

Sun Pharma’s Sezaby, used to treat infant seizures, infringes two patents says Nivagen | US firm accuses Indian rival of attempting to block patent from issuing.   25 January 2024

Pharma

Eagle Pharmaceuticals asserts new patents with trio of lawsuits over cancer drug

Complaints say Slayback, Apotex and Baxter Healthcare infringed two patents through NDAs for leukaemia drug injection | Eagle patents issued in last two months expire in 2031.   23 January 2024

Pharma

Regeneron sues Amgen over biosimilar version of blockbuster eye drug

US biotech has launched multiple suits over alleged infringement of Eylea patents | Regeneron asks US court to block Amgen’s biosimilar before potential approval.   16 January 2024

Pharma

EU: Finland liability regime 'compatible' in big pharma feud

Case concerns a supplementary protection certificate granted to Gilead by Finland’s Patent Office for a HIV drug |CJEU judges contradict AG opinion on whether a Finnish regime is at odds with an EU directive.   11 January 2024

Generics

Bayer irks High Court judge over £130k costs in refusing to produce document

Judge says Bayer racked up high costs ‘in pursuit of vague point of principle’ | Teva and others wanted presentation slides as part of patent invalidity suit.   9 January 2024

Americas

Corcept to ‘vigorously appeal’ Teva victory over Cushing’s syndrome drug patents

California-based drugmaker lost Hatch-Waxman Act case after judge ruled it had failed to show patent infringement | Corcept CEO ‘confident’ decision will be reversed on appeal.   4 January 2024

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.